SEK 15.00
-0.20 (-1.32%)
SEK · as of 2026-08-20 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where BACTI-B.ST is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
5 interventional
government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUsNCT04242706VAP incidenceRandomized · Quadruple-masked · Prevention | Phase 4 | Completed | Device: ETTEvac, BIP ETTEvac | Ventilator-associated Pneumonia | 323 | 2020-05-08actual | 2021-01-20 |
| BIP Foley in Prevention of CAUTI at Rehab StationNCT02808000Incidence of CAUTIRandomized · Single-masked · Prevention | Phase 4 | Completed | Device: BIP Foley (latex) or BIP Foley -silicone, Standard catheter | Complications; Catheter, Urinary Infection or Inflammation | 14 | 2020-03-09actual | 2021-01-22 |
| BIP CVC in Access Center at Danderyd Hospital, Stockholm, SwedenNCT03976557Number of patients with catheter related complicationsRandomized · Open-label · Prevention | Not applicable | Terminatedsponsor's stated reason: Due to Corona/Covid19 pandemic | Device: BIP CVC, Standard CVC | Vascular Access Complication, Catheter-Related Infections, Catheter Thrombosis, Catheter Blockage, Catheter Complications, Catheter Site Discomfort, Catheter Bacteraemia | 19 | 2019-12-18actual | 2021-01-22 |
| BIP CVC Clinical Safety and Performance StudyNCT02811380Assessment of safety by evaluation of CVC related adverse events and any problems in post operative course.Randomized · Single-masked · Supportive care | Phase 4 | Completed | Device: BIP CVC, Uncoated Standard CVC | Surgery, Central Line Associated Blood Stream Infections (CLABSI) | 36 | Jan 2015actual | 2016-06-23 |
| BIP ETT Clinical Tolerability, Safety and Performance StudyNCT01682486Tolerability assessment by using a symptom questionnaire (QLQ-H&N35) before and after surgery. Evaluation of tracheal mucosa directly during surgery and after the end of study by using photos.Randomized · Single-masked · Supportive care | Not applicable | Completed | Device: BIP ETT (Bactiguard) · Procedure: Standard ETT | Endotracheal Intubation During Surgery, Hospital Acquired Infections | 30 | Jan 2013actual | 2016-06-20 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-21